Effect of coinfusion of dexamethasone to oxaliplatin on hypersensitivity reactions induced by oxaliplatin in patients with colorectal cancer treated with XELOX

被引：0
|
作者：
Aisu, Naoya [1 ]
Yoshida, Yoichiro [1 ]
Miyake, Toru [1 ]
Tanimura, Syu [1 ]
Hoshino, Seiichiro [1 ]
Yamashita, Yuichi [1 ]
机构：
[1] Fukuoka Univ, Sch Med, Dept Surg Gastroenterol, Fukuoka 81401, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期
关键词：
D O I：
10.1200/jco.2013.31.4_suppl.560
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
560
引用
收藏
页数：1
相关论文
共 50 条
  • [21] SUCCESSFUL READMINISTRATION WITH OXALIPLATIN IN PATIENTS WITH ALLERGY TO OXALIPLATIN IN COLORECTAL CANCER PATIENTS
    Morikita, T.
    Sakai, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 153 - 153
  • [22] Preclinical assessment of the bioequivalence of branded and generic oxaliplatin and incidence of hypersensitivity reactions in patients with advanced colorectal cancer
    Tampellini, M.
    La Salvia, A.
    Baratelli, C.
    Di Scipio, F.
    Pirro, E.
    Brizzi, M. P.
    Sonetto, C.
    Di Maio, M.
    Berta, G. N.
    Scagliotti, G. V.
    ANNALS OF ONCOLOGY, 2016, 27
  • [23] Preclinical assessment of the bioequivalence of branded and generic oxaliplatin and incidence of hypersensitivity reactions in patients with advanced colorectal cancer
    Baratelli, C.
    Sonetto, C.
    Benedetto, S.
    Rubatto, E.
    Di Scipio, F.
    Pirro, E.
    Maria, P. Brizzi
    Di Maio, M.
    Giovanni, N. Berta
    Giorgio, V. Scagliotti
    Tampellini, M.
    ANNALS OF ONCOLOGY, 2016, 27 : 58 - 59
  • [24] A validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: The AVOID trial.
    Hirata, Keiji
    Yoshida, Yoichiro
    Matsuoka, HIroshi
    Iwamoto, Shigeyoshi
    Kotaka, Masahito
    Fujita, Hideto
    Aisu, Naoya
    Hoshino, Seiichiro
    Kosaka, Takeo
    Maeda, Kotaro
    Yamashita, Yuichi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [25] Serum Lactate Dehydrogenase Levels as a Predictive Marker of Oxaliplatin-Induced Hypersensitivity Reactions in Japanese Patients with Advanced Colorectal Cancer
    Seki, Kyoko
    Tsuduki, Yasuo
    Ioroi, Takeshi
    Yamane, Michiko
    Yamauchi, Hiroko
    Shiraishi, Yukinari
    Ogawa, Tadaaki
    Nakata, Izumi
    Nishiguchi, Kohshi
    Matsubayashi, Teruhisa
    Takakubo, Yoshihide
    Yamamori, Motohiro
    Kuwahara, Akiko
    Okamura, Noboru
    Sakaeda, Toshiyuki
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2014, 11 (06): : 641 - 645
  • [26] Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions
    Rassy, Elie
    Le Roy, Florence
    Smolenschi, Cristina
    Valery, Marine
    Boige, Valerie
    Ducreux, Michel
    Boileve, Alice
    JAMA ONCOLOGY, 2023, 9 (03) : 434 - 435
  • [27] Definition of oxaliplatin sensitivity in patients with advanced colorectal cancer previously treated with oxaliplatin-based therapy
    de Gramont Lesparre, A. H.
    Chibaudel, B.
    Bourges, O.
    Perez-Staub, N.
    Tournigand, C.
    Maindrault-Goebel, F.
    Andre, T.
    Larsen, A. K.
    Afchain, P.
    Louvet, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] DEFINITION OF OXALIPLATIN SENSITIVITY IN PATIENTS WITH ADVANCED COLORECTAL CANCER PREVIOUSLY TREATED WITH OXALIPLATIN-BASED THERAPY
    de Gramont, A.
    Chibaudel, B.
    Bourges, O.
    Perez-Staub, N.
    Tournigand, C.
    Maindrault-Goebel, F.
    Andre, T.
    Larsen, A.
    Afchain, P.
    Louvet, C.
    ANNALS OF ONCOLOGY, 2009, 20 : 13 - 13
  • [29] Effect of reduced glutathione on oxaliplatin-induced neuropathy in colorectal cancer patients
    Giampiero, R.
    Raffaele, A.
    Annamaria, B.
    Alba, C.
    Mariarosa, C.
    Pasquale, D. L.
    Alfredo, T.
    ANNALS OF ONCOLOGY, 2006, 17 : XI66 - XI66
  • [30] Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients
    Coskun, U.
    Buyukberber, S.
    Yaman, E.
    Uner, A.
    Er, O.
    Ozkan, M.
    Dikilitas, M.
    Oguz, M.
    Yildiz, R.
    Yamac, D.
    Ozturk, B.
    Kaya, A. O.
    Benekli, M.
    NEOPLASMA, 2008, 55 (01) : 65 - 70
12345